http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-117729-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
filingDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede7adcadd6021cabd2ce1b6249ded3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af226973a2cded1df8049b2cdb9fa5d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0422368122f33bd16eebeaaa8a64eae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baca39b709ae34197b53587b2b302223
publicationDate 2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-117729-A2
titleOfInvention ANTIGEN BINDING MOLECULES REPEATEDLY BINDING MULTIPLE ANTIGEN MOLECULES
abstract Antibodies with weaker antigen-binding activity at early endosomal pH than plasma pH have the ability to bind multiple antigen molecules for a single antibody molecule, have long plasma half-lives, and have more time to bind to the antigen. Claim 1: A method for dissociating within a cell an antigen from an extracellularly bound antibody, characterized in that it comprises replacing between one and nine amino acids of the antibody with histidine, or inserting between one and nine histidines in the antibody, wherein an amino acid position of the histidine substitution or histidine insertion is selected from the group consisting of H27, H31, H32, H33, H35, H50, H58, H59, H61, H62, H63, H64, H65, H99, H100b, H102, L24, L27, L28, L32, L53, L54, L56, L90, L92, and L94 according to the Kabat numbering, and the substitution or insertion of histidine increases the KD (pH5.8) / KD (pH7.4) value, defined as the ratio between antigen-binding activity at pH 5.8 and antigen-binding activity at pH 7.4, compared to the KD (pH5.8) / KD (pH7.4) value before histidine substitution or insertion, wherein the antibody binds to an antigen in the human body. Claim 9: A method for producing an antibody, characterized in that it comprises the following steps: (a) substituting between one and nine amino acids of an antibody with histidine, or inserting between one and nine histidines in an antibody, where an amino acid position of the Histidine substitution or histidine insertion is selected from the group consisting of H27, H31, H32, H33, H35, H50, H58, H59, H61, H62, H63, H64, H65, H99, H100b, H102, L24, L27 , L28, L32, L53, L54, L56, L90, L92, and L94 according to the Kabat numbering; (b) determining the antigen-binding activity of the antibody at pH 7.4; (c) determining the antigen-binding activity of the antibody at pH 5.8; (d) selecting the antibody whose antigen-binding activity at pH 7.4 is higher than the activity at pH 5.8; (e) obtaining the gene encoding the antibody selected in step (d); and (f) producing the antibody using the gene obtained in step (e).
priorityDate 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415

Total number of triples: 19.